Should insulin therapy be started earlier in type 2 diabetes patients?
DR. ABRAHAMSON of Harvard Medical School, Boston, is medical director of Joslin Diabetes Center, Boston. He is a speaker for multiple companies that market insulin, and received research support from one of them, Pfizer Inc.
PREVIEW
DR. ABRAHAMSON of Harvard Medical School, Boston, is medical director of Joslin Diabetes Center, Boston. He is a speaker for multiple companies that market insulin, and received research support from one of them, Pfizer Inc.